title: Expanding treatment options for neuromodulators: an introduction to incobotulinumtoxinA.
authors.forename: Z Paul
authors.initials: ZP
authors.lastname: Lorenc
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Kenkel
authors.forename: Steven
authors.initials: S
authors.lastname: Fagien
authors.forename: Haideh
authors.initials: H
authors.lastname: Hirmand
authors.forename: Mark S
authors.initials: MS
authors.lastname: Nestor
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Sclafani
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Sykes
authors.forename: Heidi A
authors.initials: HA
authors.lastname: Waldorf
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005145:Face; D006801:Humans; D018377:Neurotransmitter Agents / Q000627:therapeutic use*; D012060:Rejuvenation
chemical_list: D018377:Neurotransmitter Agents; D019274:Botulinum Toxins, Type A; C545476:incobotulinumtoxinA